ExpreS2ion and GenIbet sign collaboration agreement for vaccine development and GMP production
ExpreS2ion Biotech Holding AB’s fully owned subsidiary ExpreS2ion Biotechnologies ApS (“ExpreS2ion”) has signed a collaboration agreement regarding vaccine development and GMP (Good Manufacturing Practice) manufacturing with its Portuguese partner GenIbet Biopharmaceuticals, S.A. (“GenIbet”). The agreement strengthens ExpreS2ion’s position as a full-service provider from discovery up to early clinical development.The parties have signed a Memorandum of Understanding (MoU) that enables ExpreS2ion to service customers and collaboration partners across the full value chain of development of